Chiome Bioscience Inc. Financial Overview
Chiome Bioscience Inc.'s market cap is currently ¥7.28B. The company's EPS TTM is ¥-3.82; its P/E ratio is -8.03; Chiome Bioscience Inc. is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
